SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-365072
Filing Date
2017-12-08
Accepted
2017-12-11 08:15:31
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-3 d481260ds3.htm S-3 312037
2 EX-4.3 d481260dex43.htm EX-4.3 309296
3 EX-4.5 d481260dex45.htm EX-4.5 107564
4 EX-4.6 d481260dex46.htm EX-4.6 108917
5 EX-4.7 d481260dex47.htm EX-4.7 100047
6 EX-5.1 d481260dex51.htm EX-5.1 23076
7 EX-12.1 d481260dex121.htm EX-12.1 10746
8 EX-23.1 d481260dex231.htm EX-23.1 1768
9 GRAPHIC g481260g08c20.jpg GRAPHIC 36896
10 GRAPHIC g481260g17c79.jpg GRAPHIC 28507
  Complete submission text file 0001193125-17-365072.txt   1064750
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221972 | Film No.: 171248476
SIC: 2836 Biological Products, (No Diagnostic Substances)